ARBFX
Price
$13.65
Change
+$0.02 (+0.15%)
Updated
Sep 18 closing price
Net Assets
737.95M
MERFX
Price
$18.13
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Net Assets
2.4B
Interact to see
Advertisement

ARBFX vs MERFX

Header iconARBFX vs MERFX Comparison
Open Charts ARBFX vs MERFXBanner chart's image
Arbitrage R
Price$13.65
Change+$0.02 (+0.15%)
VolumeN/A
Net Assets737.95M
The Merger Fund A
Price$18.13
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets2.4B
ARBFX vs MERFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARBFX vs. MERFX commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARBFX is a Hold and MERFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MERFX has more cash in the bank: 2.4B vs. ARBFX (738M). MERFX pays higher dividends than ARBFX: MERFX (1.65) vs ARBFX (0.42). ARBFX was incepted earlier than MERFX: ARBFX (25 years) vs MERFX (37 years). ARBFX (1.78) is less costly to investors than MERFX (1.67). ARBFX is a more actively managed with annual turnover of: 162.00 vs. MERFX (153.00). ARBFX has a lower initial minimum investment than MERFX: ARBFX (2000) vs MERFX (2500). ARBFX annual gain was more profitable for investors over the last year : 6.12 vs. MERFX (5.54). MERFX return over 5 years is better than : 9.91 vs. ARBFX (4.49).
ARBFXMERFXARBFX / MERFX
Total Expense Ratio1.781.56114%
Annual Report Gross Expense Ratio1.781.67107%
Fund Existence25 years37 years-
Gain YTD5.8145.776101%
Front LoadN/A6%-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets738M2.4B31%
Annual Yield % from dividends0.421.6526%
Returns for 1 year6.125.54111%
Returns for 3 years9.379.7696%
Returns for 5 years4.499.9145%
Returns for 10 years9.6926.3037%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD1.650.14
+9.27%
Relmada Therapeutics
LRMR4.280.20
+4.90%
Larimar Therapeutics
QRVO90.042.37
+2.70%
Qorvo
CCIXU10.66N/A
N/A
Churchill Capital Corp IX
CLOV3.07N/A
N/A
Clover Health Investments Corp